WEB_Global_Banner

A Decade of Innovation, Hope and Healing: Mercy Research Marks Milestone

November 16, 2026

Key points:

  • Mercy Research is celebrating 10 years of advancing care through research and expanding patient access to clinical research.
  • Mercy Research offers more than 300 clinical trials across multiple specialties.
  • Clinical trial opportunities are available in communities across Mercy’s multi-state footprint, allowing patients to participate in care closer to home.

ST. LOUIS – With the release of its annual report, Mercy Research marks 10 years of bringing clinical trial opportunities to Mercy patients. Over the past decade, Mercy Research has grown into a nationally recognized program offering more than 300 clinical trials in specialties including cancer, cardiovascular disease, neuroscience and infectious disease.

For Mercy patients, research represents more than future discoveries. Clinical trials can provide eligible participants with early access to promising therapies, advanced diagnostics and innovative treatment approaches years before they become widely available. 

Mercy’s community-based approach opens research opportunities across its service area, helping reduce travel and financial barriers that have historically limited patient access to clinical trial participation. Three years after a pancreatic cancer diagnosis and various treatments, Deborah Cottle gained access to a then-investigational new drug through the FDA’s expanded access program (EAP) offered by Mercy Oncology and Mercy Research. Cottle was able to stay in her home community for care rather than driving hours to a larger academic site, giving her more time with her family.

Patient's Journey to Early Access Program for Promising Pancreatic Cancer Drug

Thanks to Mercy Research and its community-based approach, patients like Deborah may gain access to promising treatments before they are formally approved by the FDA.

“The structure we’ve established with researchers working at a community level highlights Mercy’s care model of accessibility and keeping patients close to home,” said JoAnne Levy, Mercy Research vice president. “We want to bring clinical trials to our patients, enabling all who qualify for a clinical trial to have access without the additional cost of travel.”

Over the past 10 years, Mercy researchers and patients have contributed to advancements in cancer early detection, heart failure treatment, proton beam therapy and sepsis identification, helping bring new discoveries from the laboratory to the bedside.

Looking ahead, Mercy Research plans to continue expanding access to clinical trials, precision medicine initiatives, AI-enabled research and innovative treatment options that help patients receive advanced care close to home.

footer-overlay_012026